New Delhi, May 13 -- Marty Makary, the 27th Commissioner of the US Food and Drug Administration, is stepping down after a turbulent tenure marked by internal upheaval, political pressure, and mounting criticism from multiple corners of the healthcare and pharmaceutical sectors.

US President Donald Trump confirmed on Tuesday (May 12) that Makary was being replaced as head of the FDA.

"He was having some difficulty," Trump told reporters at the White House.

Makary's departure comes just over a year after he was confirmed by the US Senate on March 25, 2025, in a bipartisan vote to lead one of the world's most influential health regulatory agencies.

Before joining the FDA, Makary built a high-profile career at Johns Hopkins University Sch...